Toufik Zahaf
Fleming College(CA)GlaxoSmithKline (Belgium)(BE)
Publications by Year
Research Areas
Hepatitis B Virus Studies, Herpesvirus Infections and Treatments, Cervical Cancer and HPV Research, Genital Health and Disease, Poxvirus research and outbreaks
Most-Cited Works
- → Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women(2009)1,642 cited
- → Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial(2004)1,640 cited
- → Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults(2015)1,378 cited
- → Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older(2016)1,017 cited
- → Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial(2011)502 cited
- → Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years(2009)352 cited
- → Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine(2014)248 cited
- → Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine(2012)192 cited
- → Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women(2010)169 cited
- → Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years(2008)152 cited